Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Platelet-derived growth factor-BB accelerates prostate cancer growth by promoting the proliferation of mesenchymal stem cells.

Cheng J, Ye H, Liu Z, Xu C, Zhang Z, Liu Y, Sun Y.

J Cell Biochem. 2013 Jul;114(7):1510-8. doi: 10.1002/jcb.24492.

PMID:
23297038
2.

Interleukin-1α induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells.

Cheng J, Li L, Liu Y, Wang Z, Zhu X, Bai X.

Mol Med Rep. 2012 Nov;6(5):955-60. doi: 10.3892/mmr.2012.1019. Epub 2012 Aug 7.

PMID:
22895682
3.

A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells.

Nedeau AE, Bauer RJ, Gallagher K, Chen H, Liu ZJ, Velazquez OC.

Exp Cell Res. 2008 Jul 1;314(11-12):2176-86. doi: 10.1016/j.yexcr.2008.04.007. Epub 2008 Apr 25.

4.

Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.

Zhang JM, Feng FE, Wang QM, Zhu XL, Fu HX, Xu LP, Liu KY, Huang XJ, Zhang XH.

Stem Cells Transl Med. 2016 Dec;5(12):1631-1643. Epub 2016 Jul 28.

5.

Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells.

Han Z, Tian Z, Lv G, Zhang L, Jiang G, Sun K, Wang C, Bu X, Li R, Shi Y, Wu M, Wei L.

J Cell Mol Med. 2011 Nov;15(11):2343-52. doi: 10.1111/j.1582-4934.2010.01215.x.

6.
7.

Platelet-derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells.

Kumar A, Salimath BP, Stark GB, Finkenzeller G.

Tissue Eng Part A. 2010 Mar;16(3):983-93. doi: 10.1089/ten.TEA.2009.0230.

PMID:
19839721
8.

Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer.

Brennen WN, Chen S, Denmeade SR, Isaacs JT.

Oncotarget. 2013 Jan;4(1):106-17.

9.

Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling.

Lin RZ, Moreno-Luna R, Li D, Jaminet SC, Greene AK, Melero-Martin JM.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10137-42. doi: 10.1073/pnas.1405388111. Epub 2014 Jun 30.

10.

Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.

Mognetti B, La Montagna G, Perrelli MG, Pagliaro P, Penna C.

J Cell Mol Med. 2013 Feb;17(2):287-92. doi: 10.1111/jcmm.12010. Epub 2013 Jan 10.

11.
12.

Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors.

Zhang T, Lee YW, Rui YF, Cheng TY, Jiang XH, Li G.

Stem Cell Res Ther. 2013 Jun 13;4(3):70. doi: 10.1186/scrt221.

13.

Platelet-derived growth factor (PDGF)-AA/AB in human serum are potential indicators of the proliferative capacity of human synovial mesenchymal stem cells.

Mizuno M, Katano H, Otabe K, Komori K, Matsumoto Y, Fujii S, Ozeki N, Tsuji K, Koga H, Muneta T, Matsuyama A, Sekiya I.

Stem Cell Res Ther. 2015 Dec 10;6:243. doi: 10.1186/s13287-015-0239-2.

14.

Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells.

Bocelli-Tyndall C, Zajac P, Di Maggio N, Trella E, Benvenuto F, Iezzi G, Scherberich A, Barbero A, Schaeren S, Pistoia V, Spagnoli G, Vukcevic M, Martin I, Tyndall A.

Arthritis Rheum. 2010 Dec;62(12):3815-25. doi: 10.1002/art.27736.

15.

[Effect of silencing myocardin gene expression on differentiation of mouse bone mesenchymal stem cells into smooth muscle-like cells induced by PDGF-BB].

Huang G, Xu M, Yu J, Meng H, Chen X, Li Y, Ruan QR.

Zhonghua Bing Li Xue Za Zhi. 2009 Feb;38(2):117-20. Chinese.

PMID:
19573357
16.

Impact of bladder-derived acellular matrix, growth factors, and extracellular matrix constituents on the survival and multipotency of marrow-derived mesenchymal stem cells.

Antoon R, Yeger H, Loai Y, Islam S, Farhat WA.

J Biomed Mater Res A. 2012 Jan;100(1):72-83. doi: 10.1002/jbm.a.33230. Epub 2011 Oct 4.

PMID:
21972045
17.

Locally controlling mesenchymal stem cell morphogenesis by 3D PDGF-BB gradients towards the establishment of an in vitro perivascular niche.

Lienemann PS, Devaud YR, Reuten R, Simona BR, Karlsson M, Weber W, Koch M, Lutolf MP, Milleret V, Ehrbar M.

Integr Biol (Camb). 2015 Jan;7(1):101-11. doi: 10.1039/c4ib00152d.

PMID:
25385042
18.

Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.

Hata N, Shinojima N, Gumin J, Yong R, Marini F, Andreeff M, Lang FF.

Neurosurgery. 2010 Jan;66(1):144-56; discussion 156-7. doi: 10.1227/01.NEU.0000363149.58885.2E.

19.

Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells.

Ball SG, Bayley C, Shuttleworth CA, Kielty CM.

Biochem J. 2010 Mar 15;427(1):29-40. doi: 10.1042/BJ20091512.

20.

Platelet-derived growth factor-BB enhances MSC-mediated cardioprotection via suppression of miR-320 expression.

Xu B, Luo Y, Liu Y, Li BY, Wang Y.

Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H980-9. doi: 10.1152/ajpheart.00737.2014. Epub 2015 Feb 27.

Supplemental Content

Support Center